Medicine and Dentistry
In Vitro
100%
Tumor Cell
100%
Antineoplastic Activity
100%
Tumor Cell Line
100%
Imexon
100%
Antiproliferative Activity
100%
Lymphocyte
27%
Lymphoma Cell
18%
Mitogenic Agent
18%
Cell Cycle Progression
18%
Malignant Neoplasm
9%
Disease
9%
Biopsy
9%
Cell Survival
9%
Immunosuppressive Treatment
9%
Cell Cycle
9%
Retroviridae
9%
Murine Acquired Immunodeficiency Syndrome
9%
Cytotoxicity
9%
Lymphoma
9%
SCID Mouse
9%
Splenomegaly
9%
Lymphadenopathy
9%
Protein Synthesis
9%
Myeloma Cell
9%
Myeloma Cell Line
9%
Myeloma
9%
Immune Deficiency
9%
Phoma
9%
B-Cell Lymphoma
9%
Keyphrases
Antiproliferative Activity
100%
Tumor Cells
100%
Antitumor Activity
100%
Tumor Cell Lines
100%
Imexon
100%
Myeloma Cells
18%
Inhibition Rate
18%
Lymphoma Cells
18%
Mitogen
18%
Cell Cycle Progression
18%
Macromolecular Synthesis
18%
Cytotoxicity
9%
Cell Survival
9%
Lymphoma
9%
Cell-to-cell
9%
Malignant Disease
9%
Peripheral Blood Lymphocytes
9%
Lymphadenopathy
9%
LP-BM5
9%
Retrovirus
9%
Murine AIDS
9%
Lymphocytes
9%
Protein Synthesis
9%
Biopsy Specimen
9%
Multidrug-resistant
9%
Splenomegaly
9%
Human Lymphocytes
9%
Immunosuppression
9%
Myeloma
9%
Immune-deficient Mice
9%
Inhibitory Concentration
9%
Lymphoid Malignancies
9%
Phoma
9%
Human Tumor Cells
9%
B-cell Lymphoma
9%
Chemotherapy-induced
9%
Immunodeficiency Diseases
9%